Abstract:BACKGROUND:Although a number of clinical and preclinical studies have demonstrated analgesic effects of cannabinoid treatments, there are also instances when cannabinoids have had no effect or even exacerbated pain. The observed pro-nociceptive effects appear to be due to cannabinoid-induced disinhibition of afferent synaptic input to nociceptive circuits. To better understand how cannabinoid-mediated plasticity can have both pro- and anti-nociceptive effects, we examined the possibility that cannabinoids differentially modulate nociceptive vs. non-nociceptive synapses onto a shared postsynaptic target. These experiments were carried out in the central nervous system (CNS) of the medicinal leech, in which it is possible to intracellularly record from presynaptic nociceptive (N-cell) or pressure-sensitive (P-cell) neurons and their shared postsynaptic targets.RESULTS:The endocannabinoid 2-arachidonoyl glycerol (2AG) elicited significant long-lasting depression in nociceptive (N-cell) synapses. However, non-nociceptive (P-cell) synapses were potentiated following 2AG treatment. 2AG-induced potentiation of non-nociceptive synapses was blocked by the TRPV antagonist SB366791, suggesting involvement of the same TRPV-like receptor that has already been shown to mediate endocannabinoid-dependent depression in nociceptive inputs. Treatment with the GABA receptor antagonist bicuculline also blocked 2AG-induced potentiation, consistent with the idea that increased synaptic signaling was the result of endocannabinoid-mediated disinhibition. Interestingly, while bicuculline by itself increased non-nociceptive synaptic transmission, nociceptive synapses were depressed by this GABA receptor antagonist indicating that nociceptive synapses were actually excited by GABAergic input. Consistent with these observations, GABA application depolarized the nociceptive afferent and hyperpolarized the non-nociceptive afferent.CONCLUSIONS:These findings show that endocannabinoids can differentially modulate nociceptive vs. non-nociceptive synapses and that GABAergic regulation of these synapses plays an important role in determining whether endocannabinoids have a potentiating or depressing effect.

Involvement of Glycine Receptor Α1 Subunits in Cannabinoid-Induced Analgesia.

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.

Cannabinoid Potentiation of Glycine Receptors Contributes to Cannabis-Induced Analgesia.

The Cannabinoid Dehydroxylcannabidiol Suppresses Neuropathic Pain by Upregulating a Spinal Glycine Receptor-Mediated Compensation Mechanism

Analgesic Action of Adenosine A1 Receptor Involves the Dephosphorylation of Glycine Receptor Α1ins Subunit in Spinal Dorsal Horn of Mice.

Functional expression of glycine receptors in DRG neurons of mice

Cholesterol Regulates Cannabinoid Analgesia Through Glycine Receptors.

A Common Molecular Basis For Exogenous And Endogenous Cannabinoid Potentiation Of Glycine Receptors (April, Pg 5200, 2012)

Divergent modulation of pain and anxiety by GABAergic neurons in the ventrolateral periaqueductal gray and dorsal raphe

Differential regulation of Cav 3.2 and Cav 2.2 calcium channels by CB1 receptors and cannabidiol

Evaluation of the terpenes β-caryophyllene, α-terpineol, and γ-terpinene in the mouse chronic constriction injury model of neuropathic pain: possible cannabinoid receptor involvement

Enhanced Activities Of Delta Subunit-Containing Gaba(A) Receptors Blocked Spinal Long-Term Potentiation And Attenuated Formalin-Induced Spontaneous Pain

Membrane Cholesterol Dependence of Cannabinoid Modulation of Glycine Receptor

Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia

Transcriptomic Profiling in Mice With CB1 receptor Deletion in Primary Sensory Neurons Suggests New Analgesic Targets for Neuropathic Pain

Activation of MrgC Receptor Inhibits N-type Calcium Channels in Small-Diameter Primary Sensory Neurons in Mice.

Activation of Cannabinoid CB1 Receptor Contributes to Suppression of Spinal Nociceptive Transmission and Inhibition of Mechanical Hypersensitivity by Aβ-fiber Stimulation.

GPR39 regulated spinal glycinergic inhibition and mechanical inflammatory pain

Differential Modulation of Nociceptive Versus Non-Nociceptive Synapses by Endocannabinoids.

Activation of µ-δ opioid receptor heteromers inhibits neuropathic pain behavior in rodents.